YALE UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1701-10-09
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.yale.edu
Neurobiology of Opioid Dependence: 1 - 1
Phase 2
Withdrawn
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2015-08-07
- Lead Sponsor
- Yale University
- Registration Number
- NCT00000192
- Locations
- 🇺🇸
VA Connecticut Healthcare System, New Haven, Connecticut, United States
Neurobiology of Opioid Dependence: 4 - 4
Phase 2
Withdrawn
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2016-05-06
- Lead Sponsor
- Yale University
- Registration Number
- NCT00000195
- Locations
- 🇺🇸
VA Connecticut Healthcare System, New Haven, Connecticut, United States
Neurobiology of Opioid Dependence: 5 - 5
Phase 2
Withdrawn
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2015-06-03
- Lead Sponsor
- Yale University
- Registration Number
- NCT00000196
- Locations
- 🇺🇸
VA Connecticut Healthcare System, New Haven, Connecticut, United States
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
Phase 1
Terminated
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2020-06-18
- Lead Sponsor
- Yale University
- Registration Number
- NCT00000276
- Locations
- 🇺🇸
VA Connecticut Healthcare System, New Haven, Connecticut, United States
Buprenorphine Maintenance for Opioid Addicts - 3
Phase 2
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2020-04-29
- Lead Sponsor
- Yale University
- Registration Number
- NCT00000204
- Locations
- 🇺🇸
VA Connecticut Healthcare System, New Haven, Connecticut, United States
Pharmacotherapy for Schizophrenic Drug Users - 6
Phase 2
Completed
- Conditions
- Substance-Related DisordersCocaine-Related DisordersShcizophrenia
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2016-12-15
- Lead Sponsor
- Yale University
- Registration Number
- NCT00000281
- Locations
- 🇺🇸
VA Connecticut Healthcare System, New Haven, Connecticut, United States
Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
Phase 3
Completed
- Conditions
- Opioid-Related DisordersCocaine-Related DisordersSubstance-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2020-06-29
- Lead Sponsor
- Yale University
- Registration Number
- NCT00000216
- Locations
- 🇺🇸
APT Residential Services Division, New Haven, Connecticut, United States
Novel Medications for Opiate Detoxification - 4
Phase 2
Completed
- Conditions
- Substance-Related DisordersOpioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2020-06-18
- Lead Sponsor
- Yale University
- Registration Number
- NCT00000279
- Locations
- 🇺🇸
VA Connecticut Healthcare System, New Haven, Connecticut, United States
Mazindol for Cocaine Abuse - 2
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2020-06-18
- Lead Sponsor
- Yale University
- Registration Number
- NCT00000277
- Locations
- 🇺🇸
VA Connecticut Healthcare System, New Haven, Connecticut, United States
Neurobiology of Opioid Dependence: 2 - 2
Phase 2
Withdrawn
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2015-08-07
- Lead Sponsor
- Yale University
- Registration Number
- NCT00000193
- Locations
- 🇺🇸
VA Connecticut Healthcare System, New Haven, Connecticut, United States